Article
Matrix metalloproteinases: a therapeutic target in cardiovascular disease.
Current pharmaceutical design - 1 Jan 2003
Sierevogel M J, Pasterkamp G, de Kleijn D P V, Strauss B H
Abstract excerpt
Cardiovascular disease is the leading cause of death in Western society. Extracellular matrix turnover is important in many cardiovascular pathologies, such as arterial remodeling, plaque rupture, restenosis, aneurysm formation and heart failure. Matrix metalloproteinases (MMPs) belong to a group of zinc and calcium dependent proteases and cause breakdown of the extracellular matrix. MMP inhibitors have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
